Market closed
Eurofins Scientific/€ERF
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Eurofins Scientific
Eurofins Scientific, with the ticker ERF, is a global bio-analytical testing providing services across several industries including pharmaceutical, food, environmental, and consumer products. Founded in 1987, the company specializes in delivering analytical testing and advisory services to ensure product safety and compliance with regulations. Eurofins operates through a decentralized network of laboratories, serving customers worldwide to enhance health and safety standards.
Ticker
€ERF
Sector
Trading on
PAR
Industry
Life Sciences Tools & Services
Headquarters
Luxembourg City, Luxembourg
Employees
61,798
Website
ERF Metrics
BasicAdvanced
€9.1B
Market cap
31.00
P/E ratio
€1.55
EPS
0.68
Beta
€0.50
Dividend rate
1.04%
Dividend yield
Price and volume
Market cap
€9.1B
Beta
0.68
52-week high
€62.10
52-week low
€39.47
Average daily volume
381K
Dividend rate
€0.50
Financial strength
Current ratio
1.419
Quick ratio
1.203
Long term debt to equity
63.678
Total debt to equity
66.906
Dividend payout ratio (TTM)
59.09%
Interest coverage (TTM)
5.80%
Management effectiveness
Return on assets (TTM)
4.85%
Return on equity (TTM)
7.27%
Valuation
Price to earnings (TTM)
31.004
Price to revenue (TTM)
1.377
Price to book
2.16
Price to tangible book (TTM)
-7.02
Price to free cash flow (TTM)
13.721
Dividend yield (TTM)
1.04%
Forward dividend yield
1.04%
Growth
Revenue change (TTM)
3.28%
Earnings per share change (TTM)
-20.17%
3-year revenue growth (CAGR)
1.72%
3-year earnings per share growth (CAGR)
-26.00%
3-year dividend per share growth (CAGR)
-9.74%
What the Analysts think about ERF
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Eurofins Scientific stock.
ERF Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ERF Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
FAQs
What’s the current market cap for Eurofins Scientific stock?
Eurofins Scientific (ERF) has a market cap of €9.1B as of December 15, 2024.
What is the P/E ratio for Eurofins Scientific stock?
The price to earnings (P/E) ratio for Eurofins Scientific (ERF) stock is 31 as of December 15, 2024.
Does Eurofins Scientific stock pay dividends?
Yes, the Eurofins Scientific (ERF) stock pays dividends to shareholders. As of December 15, 2024, the dividend rate is €0.5 and the yield is 1.04%. Eurofins Scientific has a payout ratio of 59.09% on a trailing twelve-month basis.
When is the next Eurofins Scientific dividend payment date?
The next Eurofins Scientific (ERF) dividend payment date is unconfirmed.
What is the beta indicator for Eurofins Scientific?
Eurofins Scientific (ERF) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.